Announced Tue, 16 Sept · 17:07 IST
Procter & Gamble Health Limited has informed the Exchange regarding Appointment of Mr Shashank Srowthy as Chief Financial Officer of the company w.e.f. October 01, 2025.
Management Changes View source PDF
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Procter & Gamble Health Limited has appointed Mr Shashank Srowthy as the new Chief Financial Officer of the company, effective from October 01, 2025. This is a key managerial personnel (KMP) change at the finance leadership level. No further details about the outgoing CFO or transition plan were mentioned in the filing.
Likely market impact
A new CFO appointment typically signals a leadership transition, which may or may not affect strategy or financial reporting direction. Shareholders should watch for any related disclosures about the previous CFO's departure and the new CFO's background.